Literature DB >> 31894419

Neural and dopaminergic correlates of fatigue in Parkinson's disease.

Suk Yun Kang1, Mirim Bang2, Jing Yong Hong3, Jungsu Oh4, Jae Seung Kim4, You Mie Han5, Suk Ki Chang6, Seun Ah Lee6, Uicheul Yoon7, Na-Young Shin8.   

Abstract

Fatigue is one of the most common non-motor symptoms in Parkinson's disease (PD). Despite its clinical importance, there are few studies on the cause or mechanism of fatigue. Our aim was to find brain areas related to fatigue and to explore the association between striatal dopaminergic dysfunction and fatigue. We consecutively screened forty-seven patients with de novo PD from 2012 to 2017 and enrolled 32 patients. The gray matter volumes, white matter tracts, and striatal dopaminergic activity between PD without fatigue and with fatigue were compared. The correlation between fatigue and striatal dopaminergic activity was also analyzed. Our data did not show any significant difference in gray matter volume between PD without fatigue and with fatigue (familywise error [FWE] corrected p > 0.05) but revealed significantly higher mean fractional anisotropy (FA) values for all analyzed white matter tracts in PD with fatigue (false discovery rate [FDR] corrected p < 0.05), except left cingulum-hippocampus (CH), right superior longitudinal fasciculus, and right longitudinal fasciculus temporal part (FDR corrected p > 0.06); lower mean diffusivity (MD) values for all analyzed white matter tracts in PD with fatigue (FDR corrected p < 0.05), except in the left CH and uncinate fasciculus (FDR corrected p > 0.05). The mean radial diffusivity (RD) values, except for the left CH (FDR corrected p = 0.0576), were also significantly lower (FDR corrected p < 0.05). There was no difference in dopaminergic deficits between PD without fatigue and PD with fatigue (p > 0.50). The alteration of the white matter tract may reflect the degree of fatigue in PD. This is not true of the gray matter and striatal dopaminergic activity. These results show the possibility that white matter changes can be used as a biomarker for fatigue.

Entities:  

Keywords:  Diffusion tensor imaging; Dopamine; Fatigue; MRI; PET; Parkinson’s disease

Mesh:

Substances:

Year:  2020        PMID: 31894419     DOI: 10.1007/s00702-019-02130-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  37 in total

1.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis.

Authors:  M Cercignani; M Inglese; E Pagani; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

2.  Neuroimaging and clinical predictors of fatigue in Parkinson disease.

Authors:  Kelvin L Chou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2015-12-02       Impact factor: 4.891

Review 3.  Diffusion tensor imaging of the brain.

Authors:  Andrew L Alexander; Jee Eun Lee; Mariana Lazar; Aaron S Field
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Association between autonomic dysfunction and fatigue in Parkinson disease.

Authors:  Kelvin L Chou; Sid Gilman; Nicolaas I Bohnen
Journal:  J Neurol Sci       Date:  2017-04-17       Impact factor: 3.181

5.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

6.  Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.

Authors:  Sang Soo Cho; Kelly Aminian; Crystal Li; Anthony E Lang; Sylvain Houle; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2016-08-29       Impact factor: 5.038

Review 7.  Interventions for fatigue in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Marloes Franssen; Charlotte Winward; Johnny Collett; Derick Wade; Helen Dawes
Journal:  Mov Disord       Date:  2014-09-18       Impact factor: 10.338

Review 8.  Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Mahsa Dolatshahi; Farzaneh Ghazi Sherbaf; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-07-26       Impact factor: 4.003

9.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia.

Authors:  Gwenaëlle Douaud; Stephen Smith; Mark Jenkinson; Timothy Behrens; Heidi Johansen-Berg; John Vickers; Susan James; Natalie Voets; Kate Watkins; Paul M Matthews; Anthony James
Journal:  Brain       Date:  2007-08-13       Impact factor: 13.501

Review 10.  Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis.

Authors:  Cyril Atkinson-Clement; Serge Pinto; Alexandre Eusebio; Olivier Coulon
Journal:  Neuroimage Clin       Date:  2017-07-15       Impact factor: 4.881

View more
  3 in total

1.  Impaired Interhemispheric Synchrony in Parkinson's Disease with Fatigue.

Authors:  Yong-Sheng Yuan; Min Ji; Cai-Ting Gan; Hui-Min Sun; Li-Na Wang; Ke-Zhong Zhang
Journal:  J Pers Med       Date:  2022-05-27

2.  Fatigue in Brazilian patients with Parkinson's disease.

Authors:  Daniel Venturino Nassif; João Santos Pereira
Journal:  Dement Neuropsychol       Date:  2022-05-13

3.  Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1 -selective modulation.

Authors:  Yasuyuki Kihara; Deepa Jonnalagadda; Yunjiao Zhu; Manisha Ray; Tony Ngo; Carter Palmer; Richard Rivera; Jerold Chun
Journal:  FASEB J       Date:  2022-02       Impact factor: 5.834

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.